Clinical Practice Guidelines by Tumour Type

The ESMO Clinical Practice Guidelines (CPG) are intended to provide oncology professionals with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.

Produced under the direction of the ESMO Guidelines Committee, each Clinical Practice Guideline includes information on the incidence of the malignancy, diagnostic criteria, staging of disease and risk assessment, treatment plans and follow-up designed to help oncologists deliver an appropriate quality of care to their patients.

New for 2016: Acute lymphoblastic leukaemia and extranodal diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.